RECQL and cancer: Given that the RECQ1 protein restarts replication forks stalled by DNA damaging agents and allows some cancer cells to survive the cytotoxic effect of this class of chemotherapeutic drugs, the downregulation of RECQ1 could be effective in treating cancer patients.